ICPT — Intercept Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $793.52m
- $713.07m
- $285.71m
Intercept rises on positive data from liver disease therapy study
Brief: Intercept Announces New Data Showing Potential Of Fixed-Dose Combination Of OCA And Bezafibrate
U.S. RESEARCH ROUNDUP- Kenvue, Universal Health Services, Workday
U.S. RESEARCH ROUNDUP-Cleveland-Cliffs, Graftech International, Steel Dynamics
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
Intercept tumbles on concerns over prospects of fatty liver disease drug (updated)
U.S. STOCKS ON THE MOVE-NuScale Power Corp, Foot Locker, Greenhill
Intercept tumbles after FDA panel votes against approval of fatty liver disease drug
Intercept shares tumble on concerns over NASH drug prospects
US FDA panel votes against approval of Intercept fatty liver drug, cites safety issues (updated)
Brief: US FDA panel votes against accelerated approval of Intercept's fatty liver drug
US FDA panel votes against accelerated approval of Intercept fatty liver drug
U.S. STOCKS ON THE MOVE-Stereotaxis, AbbVie, CureVac
U.S. STOCKS ON THE MOVE-GoHealth, Hologic, LyondellBasell
Intercept Pharma shares on trading halt before FDA panel meet on NASH drug
Brief: Intercept Pharmaceuticals Stock Trading Halted Today
Brief: Intercept Pharmaceuticals Inc On May 15 Entered Agreement For Supply Of Manufactured Products
U.S. RESEARCH ROUNDUP-Amyris, APi Group, Rambus